Wikidata

(Q47861588)

English

Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.

scientific article published in February 2005

In more languages

Statements

title
Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15664480
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15664480%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q47861588&oldid=2158615710"